SEC 13F Intelligence

Seascape Capital Management / ABBV

Seascape Capital Management’s Abbvie Inc Position

Does Seascape Capital Management own Abbvie Inc (ABBV)? Yes28.3K shares worth $6M (+1.77% of its 13F portfolio) as of Q1 2026, up from 27.9K shares the prior filed quarter.

Position Value
$6M
Q1 2026
Shares
28.3K
% of Portfolio
+1.77%
Quarters Held
26
currently held

Position History ABBV

Reported value by quarter
Q4 ’19: $2MQ4 ’19Q1 ’20: $2MQ2 ’20: $2MQ3 ’20: $2MQ4 ’20: $3MQ4 ’20Q1 ’21: $3MQ2 ’21: $3MQ3 ’21: $3MQ4 ’21: $4MQ4 ’21Q1 ’22: $5MQ2 ’22: $4MQ3 ’22: $4MQ4 ’22: $5MQ4 ’22Q1 ’23: $4MQ2 ’23: $4MQ3 ’23: $4MQ4 ’23: $4MQ4 ’23Q1 ’24: $5MQ2 ’24: $5MQ3 ’24: $5MQ4 ’24: $5MQ4 ’24Q1 ’25: $6MQ2 ’25: $5MQ3 ’25: $6MQ4 ’25: $6MQ4 ’25Q1 ’26: $6Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202628.3K$6M+1.77%
Q4 202527.9K$6M+1.82%
Q3 202527.5K$6M+1.83%
Q2 202526.9K$5M+1.58%
Q1 202527.1K$6M+1.98%
Q4 202427.5K$5M+1.70%
Q3 202427.1K$5M+1.91%
Q2 202427.8K$5M+1.78%
Q1 202427.4K$5M+1.86%
Q4 202328.0K$4M+1.83%
Q3 202327.4K$4M+1.94%
Q2 202327.3K$4M+1.74%
Q1 202327.5K$4M+2.23%
Q4 202229.9K$5M+2.63%
Q3 202230.4K$4M+2.80%
Q2 202228.6K$4M+2.66%
Q1 202228.6K$5M+2.40%
Q4 202128.9K$4M+1.83%
Q3 202128.2K$3M+1.56%
Q2 202126.0K$3M+1.52%
Q1 202125.6K$3M+1.54%
Q4 202025.6K$3M+1.60%
Q3 202024.3K$2M+1.35%
Q2 202024.4K$2M+1.72%
Q1 202026.1K$2M+1.80%
Q4 201925.8K$2M+1.63%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Seascape Capital Management’s full portfolio or all institutional holders of ABBV.